The purpose of this study has been to describe test procedures for measuring the (sub)chronic effects of chemicals on the freshwater cyclopoid Eucyclops serrulatus. To this end we have adapted the setting of the standard full life-cycle protocol of the marine harpacticoid A. tenuiremis to E. serrulatus. We have tested the effects of 4 different diets, two temperatures and two rearing volumes on the survival, development, reproduction and population growth rates of this species. Our results have highlighted that full life-cycle tests can be run using 2 mL-glass vials, a diet consisting of a mixture of living cells of Chlorella sorokiniana and Scenedesmus quadricauda, at either 25 °C (test duration: 42 days) or 18 °C (test duration: 51 days). However, the best performance in terms of survival, development, reproducibility and population growth rates with this species was obtained at 18 °C, albeit with significantly longer test duration. Subchronic tests in 2 mL-glass vials with the mixture microalgal diet at both temperatures are available options if considered appropriate for the objectives of a given study. In particular, developmental tests from nauplius to copepodid may profitably be performed in about 11 days at 18 °C and in 6 days at 25 °C. Under the same test conditions, subchronic tests from copepodid to adult may be run in 19 days at 18 °C and in 16 days at 25 °C.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chemosphere.2016.12.151 | DOI Listing |
Sci Rep
December 2024
Faculty of Sports and Exercise Science, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Wheelchair propulsion is a fundamental skill in wheelchair sports, particularly in wheelchair tennis. To achieve optimal mobility during wheelchair athletic performance, it is essential to consider propulsion techniques. This study examines the effect of push frequency and stroke duration on wheelchair maneuverability, measured by velocity during propulsion, among wheelchair tennis athletes.
View Article and Find Full Text PDFJ Neurol
December 2024
Department of Neurosciences Rita Levi Montalcini, University of Turin, Turin, Italy.
Introduction: Non-motor symptoms (NMS) in Parkinson's disease (PD) can fluctuate daily, impacting patient quality of life. The Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire, a recently validated tool, quantifies NMS fluctuations during ON- and OFF-medication states. Our study aimed to validate the Italian version of NoMoFA, comparing its results to the original validation and further exploring its clinimetric properties.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Statistical Science, Duke University, Durham, 27708-0251, USA.
The article is motivated by an application to the EarlyBird cohort study aiming to explore how anthropometrics and clinical and metabolic processes are associated with obesity and glucose control during childhood. There is interest in inferring the relationship between dynamically changing and high-dimensional metabolites and a longitudinal response. Important aspects of the analysis include the selection of the important set of metabolites and the accommodation of missing data in both response and covariate values.
View Article and Find Full Text PDFSci Rep
December 2024
Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Early detection of a premetabolic status that is at risk for metabolic syndrome (MetS) but not meeting the criteria is crucial. This study examined 27,623 participants aged 20-50 (mean: 40.7) years who underwent initial health screening at Kangbuk Samsung Hospital (2011-2019), focusing on individuals with one or two MetS components.
View Article and Find Full Text PDFSci Rep
December 2024
Cardiopulmonary Physiotherapy Laboratory, Physical Therapy Department, Universidade Federal de São Carlos, Rodovia Washington Luiz, São Carlos, SP, 13565-905, Brazil.
This study investigated the impact of mild COVID-19 on HRV in groups stratified by time after infection and to compare to a healthy group of the same age without previous virus infection and without need of hospitalization. This is a cross-sectional study. We divided the sample into four groups: control group (CG) (n = 31), group 1 (G1): ≤6 weeks (n = 34), group 2 (G2): 2-6 months (n = 30), group 3 (G3): 7-12 months (n = 35) after infection.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!